Breaking News Instant updates and real-time market news.

IOVA

Iovance Biotherapeutics

$14.60

0.75 (5.42%)

16:08
08/06/18
08/06
16:08
08/06/18
16:08

Iovance expects update on melanoma program later this year

The company said in today's earnings release, "The dosing of the first patient with lifileucel in Europe for the treatment of metastatic melanoma marked an important milestone for Iovance and our global development plans as we continue our mission to develop TIL therapy as a treatment option for cancer patients. In line with expansion of the TIL platform, we are initiating investigation of TIL therapy in several new indications with high unmet need, as part of our collaboration with MD Anderson. We continue to advance our four company-sponsored trials and intend to provide an update regarding our melanoma program later this year." It added that enrollment in its global Phase 2 metastatic melanoma study, C-144-01, continues.

  • 06

    Aug

  • 08

    Aug

  • 16

    Aug

  • 04

    Sep

IOVA Iovance Biotherapeutics
$14.60

0.75 (5.42%)

06/13/18
HCWC
06/13/18
NO CHANGE
Target $22
HCWC
Buy
Iovance thesis supported by recent TIL news, says H.C. Wainwright
Shares of Iovance Biotherapeutics dropped pre- and post-ASCO without any tangible reasons to point to for the weakness, H.C. Wainwright analyst Joseph Pantginis tells investors in a research note. The analyst believes news in the TIL arena at ASCO and a recent Nature Medicine publication "only support a key factor" to his investment case. The more solid tumor data using TILs beyond melanoma support continued differentiation versus CAR-Ts, Pantginis contends. The analyst believes the Iovance investment thesis "remains strong" and he keeps a Buy rating on the shares with a $22 price target.
06/08/18
WELS
06/08/18
NO CHANGE
Target $23
WELS
Outperform
Iovance confusion creates buying opportunity, says Wells Fargo
Wells Fargo analyst Jim Birchenough reiterates an Outperform rating on Iovance Biotherapeutics with a $23 price target following expansion of patient dosing with its bulk TIL product LN-144 in Europe for melanoma. Further, a publication by collaborators at the National Cancer Institute on a selected TIL product in advanced breast cancer highlights the opportunity for "next-generation" TIL therapeutics, Birchenough tells investors in a research note. The value of a "commercially scalable and competitive" three-week TIL product with clinical validation across refractory melanoma, head and neck cancer and cervical cancer has been under-appreciated in Iovance shares, the analyst contends. Further, Birchenough thinks confusion over implications of a "next-gen" selective TIL product with durable 22 month complete response in late line metastatic breast cancer provides an opportunity for investors.
05/11/18
RILY
05/11/18
NO CHANGE
Target $24
RILY
Buy
Iovance price target raised to $24 from $22 at B. Riley FBR
B. Riley FBR analyst Madhu Kumar raised his price target for Iovance Biotherapeutics to $24 following last night's Q1 results. The analyst believes FDA interactions in Q3 could set an approval path for melanoma TILs. He reiterates a Buy rating on the shares.
04/10/18
RILY
04/10/18
UPGRADE
Target $22
RILY
Buy
Iovance Biotherapeutics upgraded to Buy from Neutral at B. Riley FBR
B. Riley FBR analyst Madhu Kumar upgraded Iovance Biotherapeutics to Buy with an unchanged price target of $22. The recent pullback in the shares ignores the long-term potential of tumor infiltrating lymphocytes, Kumar tells investors in a research note.

TODAY'S FREE FLY STORIES

DRI

Darden

$119.14

1.22 (1.03%)

06:22
04/26/19
04/26
06:22
04/26/19
06:22
Initiation
Darden initiated  »

Darden initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAKE

Cheesecake Factory

$49.28

0.29 (0.59%)

06:22
04/26/19
04/26
06:22
04/26/19
06:22
Initiation
Cheesecake Factory initiated  »

Cheesecake Factory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 10

    Jun

PKG

Packaging Corp.

$97.96

-0.9 (-0.91%)

06:21
04/26/19
04/26
06:21
04/26/19
06:21
Downgrade
Packaging Corp. rating change  »

Packaging Corp.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

  • 13

    Nov

VFC

VF Corp.

$94.00

-0.72 (-0.76%)

06:20
04/26/19
04/26
06:20
04/26/19
06:20
Hot Stocks
VF Corp. provides initial 2020-2021 outlook for Kontoor Brands »

Kontoor Brands'…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NESR

National Energy Services

$10.65

-0.07 (-0.65%)

06:20
04/26/19
04/26
06:20
04/26/19
06:20
Conference/Events
National Energy Services management to meet with Maxim »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 03

    May

UBS

UBS

06:20
04/26/19
04/26
06:20
04/26/19
06:20
Downgrade
UBS rating change  »

UBS downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 03

    Jun

ESPR

Esperion

$43.02

1.14 (2.72%)

06:19
04/26/19
04/26
06:19
04/26/19
06:19
Upgrade
Esperion rating change  »

Goldman upgrades Esperion…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    May

  • 07

    May

VFC

VF Corp.

$94.00

-0.72 (-0.76%)

06:19
04/26/19
04/26
06:19
04/26/19
06:19
Earnings
VF Corp. sees Kontoor Brands FY19 revenue exceeding $2.5B »

The initial outlook for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBR

Petrobras

$15.47

0.13 (0.85%)

06:17
04/26/19
04/26
06:17
04/26/19
06:17
Hot Stocks
Petrobras executes three agreements for sale of assets totaling $10.3B »

Petrobras said it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$193.23

10.59 (5.80%)

06:17
04/26/19
04/26
06:17
04/26/19
06:17
Periodicals
FTC officials mull constraints for Facebook's business practices, NY Times says »

Members of the Federal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 30

    May

  • 03

    Jun

WDC

Western Digital

06:17
04/26/19
04/26
06:17
04/26/19
06:17
Downgrade
Western Digital rating change  »

Western Digital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Apr

IRM

Iron Mountain

$32.67

-3.17 (-8.84%)

06:17
04/26/19
04/26
06:17
04/26/19
06:17
Downgrade
Iron Mountain rating change  »

Iron Mountain downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 04

    Jun

GLNCY

Glencore

$0.00

(0.00%)

06:17
04/26/19
04/26
06:17
04/26/19
06:17
Conference/Events
Glencore management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 02

    May

  • 03

    May

CAE

CAE

$23.23

0.205 (0.89%)

06:16
04/26/19
04/26
06:16
04/26/19
06:16
Downgrade
CAE rating change  »

CAE downgraded to Sector…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BOLD

Audentes Therapeutics

$40.22

-0.32 (-0.79%)

06:16
04/26/19
04/26
06:16
04/26/19
06:16
Downgrade
Audentes Therapeutics rating change  »

Audentes Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    May

MDCO

The Medicines Co.

$29.84

0.37 (1.26%)

06:15
04/26/19
04/26
06:15
04/26/19
06:15
Upgrade
The Medicines Co. rating change  »

Goldman Sachs sees 90%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    May

  • 08

    May

RACE

Ferrari

$135.57

-0.91 (-0.67%)

06:15
04/26/19
04/26
06:15
04/26/19
06:15
Downgrade
Ferrari rating change  »

Ferrari downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

QRVO

Qorvo

$77.33

0.09 (0.12%)

06:14
04/26/19
04/26
06:14
04/26/19
06:14
Downgrade
Qorvo rating change  »

Qorvo downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

AUY

Yamana Gold

$2.20

-0.015 (-0.68%)

06:14
04/26/19
04/26
06:14
04/26/19
06:14
Downgrade
Yamana Gold rating change  »

Yamana Gold downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

AMZN

Amazon.com

$1,902.53

1.81 (0.10%)

06:14
04/26/19
04/26
06:14
04/26/19
06:14
Periodicals
Amazon is preparing hi-definition music streaming service, MBW says »

Soon after Amazon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    May

  • 22

    May

  • 03

    Jun

PKG

Packaging Corp.

$97.96

-0.9 (-0.91%)

06:12
04/26/19
04/26
06:12
04/26/19
06:12
Downgrade
Packaging Corp. rating change  »

Packaging Corp.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

  • 13

    Nov

CTRP

Ctrip

$42.51

-0.44 (-1.02%)

06:12
04/26/19
04/26
06:12
04/26/19
06:12
Hot Stocks
Ctrip announces share exchange transaction with Naspers »

Ctrip announced a share…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNSL

Consolidated Communications

$5.86

-3.03 (-34.08%)

06:11
04/26/19
04/26
06:11
04/26/19
06:11
Downgrade
Consolidated Communications rating change  »

Consolidated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Apr

VZ

Verizon

$55.86

-1.2 (-2.10%)

, SSNLF

Samsung

$0.00

(0.00%)

06:11
04/26/19
04/26
06:11
04/26/19
06:11
Hot Stocks
Verizon waives plan to charge for 5G »

Verizon (VZ) said…

VZ

Verizon

$55.86

-1.2 (-2.10%)

SSNLF

Samsung

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 20

    May

ZBH

Zimmer Biomet

$124.78

0.31 (0.25%)

06:10
04/26/19
04/26
06:10
04/26/19
06:10
Earnings
Zimmer Biomet backs FY19 adj. EPS view of $7.70-$7.90, consensus $7.80 »

Backs FY19 revenue growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 10

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.